Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons
Stem Cells Translational Medicine · 2024
DOI: 10.1093/stcltm/szae066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Keitaro Yamagami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Progranulins, Induced Pluripotent Stem Cells, Neurons. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Cerebral organoids (COs) in cell replacement therapy offer a viable approach to reconstructing neural circuits for individuals suffering from stroke or traumatic brain injuries. Successful transplantation relies on effective engraftment and neurite extension from the grafts. Earlier research has validated the effectiveness of delaying the transplantation procedure by 1 week. Here, we hypothesized that brain tissues 1 week following a traumatic brain injury possess a more favorable environment for cell transplantation when compared to immediately after injury. We performed a transcriptomic comparison to differentiate gene expression between these 2 temporal states. In controlled in vitro conditions, recombinant human progranulin (rhPGRN) bolstered the survival rate of dissociated neurons sourced from human induced pluripotent stem cell-derived COs (hiPSC-COs) under conditions of enhanced oxidative stress. This increase in viability was attributable to a reduction in apoptosis via Akt phosphorylation. In addition, rhPGRN pretreatment before in vivo transplantation experiments augmented the engraftment efficiency of hiPSC-COs considerably and facilitated neurite elongation along the host brain’s corticospinal tracts. Subsequent histological assessments at 3 months post-transplantation revealed an elevated presence of graft-derived subcerebral projection neurons—crucial elements for reconstituting neural circuits—in the rhPGRN-treated group. These outcomes highlight the potential of PGRN as a neurotrophic factor suitable for incorporation into hiPSC-CO-based cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
- Department of Neurosurgery, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
ORCID-Profile: Keitaro Yamagami
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Yamagami, K., Samata, B., Doi, D., Tsuchimochi, R., Kikuchi, T., Amimoto, N., Ikeda, M., Yoshimoto, K., & Takahashi, J. (2024). Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae066
Vancouver
Yamagami K, Samata B, Doi D, Tsuchimochi R, Kikuchi T, Amimoto N, et al. Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szae066
BibTeX
@article{Yamagami2024,
author = {Yamagami, Keitaro and Samata, Bumpei and Doi, Daisuke and Tsuchimochi, Ryosuke and Kikuchi, Tetsuhiro and Amimoto, Naoya and Ikeda, Megumi and Yoshimoto, Koji and Takahashi, Jun},
title = {Progranulin enhances the engraftment of transplanted human iPS cell-derived cerebral neurons},
journal = {Stem Cells Translational Medicine},
year = {2024},
doi = {10.1093/stcltm/szae066}
}
EUVIMED